© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
568722 |
As an accredited 5-Bromo-[1,2,4]Triazolo[1,5-A]Pyridin-2-Ylamine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 5-Bromo-[1,2,4]Triazolo[1,5-A]Pyridin-2-Ylamine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Research in the chemical sciences always finds itself evolving alongside the demands of our world, and in my experience, the building blocks we select often set the pace for how quickly we can explore new ideas. 5-Bromo-[1,2,4]Triazolo[1,5-A]pyridin-2-ylamine stands out in this constant race. Over the last decade, I’ve watched both academic and industrial chemists gravitate toward molecular scaffolds that tame reactivity and promise reliability, especially ones that offer halogen compatibility. The bromine atom positioned on this molecule does more than mark a point of interest; it invites creative possibilities for synthetic expansion, especially through well-established coupling reactions.
A closer look at the molecule itself shows why it has grabbed attention in medicinal and materials chemistry. The combination of the triazolo core with a pyridyl ring forms a rigid, planar system. This arrangement brings stability and unique electron distribution. That flatness, in my hands, can make a real difference when screening for drug-like properties—compounds with planar, fused heterocycles often behave predictably in early assays. The amine group at the 2-position of the triazolo ring not only enables the formation of key hydrogen bonds but takes part in further modification, ramping up the molecule's value in lead optimization.
When using 5-Bromo-[1,2,4]triazolo[1,5-a]pyridin-2-ylamine during my graduate research, what stood out wasn’t just structural intrigue—it was how it fit into routine lab workflows. The molecule often comes in a light to tan powder form, easy to weigh out and dissolve in standard polar organic solvents. I’ve found this to reduce trial-and-error time, especially for those running parallel synthesis or scale-up batches. Storage is straightforward: the compound remains stable at room temperature if kept away from strong acids and bases. That shelf life, I found out the hard way with other triazole analogs, can’t be taken for granted.
Chemists always value options. On more than one occasion, I sought out molecules that stand up to rigorous substitutions and coupling reactions without decomposing. The bromine atom at the 5-position is particularly inviting for palladium-catalyzed cross-coupling—Suzuki, Sonogashira, and Buchwald-Hartwig reactions fit the bill. In my own synthesis of kinase inhibitor scaffolds, this bromo derivative gave much cleaner conversions compared to its chloro or iodo siblings. That’s due to the sweet spot bromine hits for reactivity—iodides can be too reactive and sometimes lead to messy mixtures, chlorides too reluctant to leave. The 2-ylamine group doesn’t just dangle passively; it opens doors for direct amidation, sulfonylation, and other nucleophilic additions.
Any medicinal chemist aiming for a new inhibitor or probe molecule wants a scaffold that supports quick analog generation. In my experience iterating through SAR, 5-Bromo-[1,2,4]triazolo[1,5-a]pyridin-2-ylamine fits well with modular strategies. Its fused heterocycle tolerates substitutions that others don’t. Compared to structurally similar compounds—say, non-brominated triazolopyridines—having that bromine makes late-stage diversification feasible. So, as I look at competition between different lead series, this amine lets me install a wide range of functionalities without complex protecting group gymnastics.
Lab work only moves as fast as you can trust your starting materials. Early on, I remember wading through batches of various triazole building blocks, never sure if impurities would throw off my results. Sourcing 5-Bromo-[1,2,4]triazolo[1,5-a]pyridin-2-ylamine from reputable suppliers brought a level of analytical clarity. The product typically arrives with purity exceeding 98% by HPLC or NMR review, minimizing surprises down the line. This purity isn’t just a number; in my projects, I’ve seen how even minor contaminants skew bioactivity data or reduce yield, forcing laborious repeat reactions. Experience with both academic and CRO environments points to the value of investing in materials where identity and freshness are routinely documented.
Innovation in chemistry seeps across boundaries. The triazolopyridine framework, with its brominated version, has played roles not only in small molecule drug discovery. Researchers have also spotted its value in the field of materials—and not just on paper. Luminophores, organic field-effect transistors, and sensors make use of these sorts of rigid aromatic systems. From my own forays into supramolecular chemistry, I found the molecule’s planarity aids in stacking and self-assembly—a distinct advantage over bulkier, less planar analogs.
Choice matters, especially in fields flush with similar-looking molecules. Comparing 5-Bromo-[1,2,4]triazolo[1,5-a]pyridin-2-ylamine to related triazolopyridine derivatives, the inclusion of bromine always gives it a leg up in terms of further functionalization. Some chemists lean on iodo variants for their reactivity, but those often come with trade-offs in stability and handling. Chloro derivatives last longer on the shelf but generally make for slower coupling reactions. In my hands, the bromo stands as the middle ground—solid, reliable, and reactive enough without the fuss.
Development teams have sometimes tried non-halogenated triazolopyridine scaffolds for similar targets. These lack the touchpoint for late-stage diversification, which often limits their utility in quickly generating broad SAR libraries. Over the years, I’ve seen projects stall because every new modification required a whole new synthetic pathway—painstaking, slow, expensive. With 5-Bromo-[1,2,4]triazolo[1,5-a]pyridin-2-ylamine, that risk falls away, making it my preferred choice when speed and variety matter.
Reproducibility sits at the core of any science-driven effort. Only through robust, transparent chemistry does research build the confidence to step forward. Using standardized building blocks like this molecule pushes projects forward with fewer missteps. In my time mentoring new lab members, nothing builds their confidence like knowing the next step in a synthetic route won’t unravel because of an unpredictable intermediate.
Throughout a dozen projects, both academic and industrial, there’s comfort knowing that 5-Bromo-[1,2,4]triazolo[1,5-a]pyridin-2-ylamine doesn’t pose unusual hazards. Standard personal protective gear—gloves, goggles, lab coats—keeps handling risks minimal. It needs no unusual containment beyond what is routine for basic organic powders. Spills clean up with the regular bench top protocol; proper ventilation carries off any minor dust. Chemists appreciate that peace of mind comes not just from accident records but from years of uneventful, routine use.
The chemical toolbox always grows, and so do expectations for what a building block should deliver. Having run structure elaborations with both classical and modern techniques, I’ve found that 5-Bromo-[1,2,4]triazolo[1,5-a]pyridin-2-ylamine doesn’t just end up as a dead-end intermediate. It regularly forms the heart of kinase inhibitors, ligands, and fluorescent probes. That speaks volumes about its underlying value. Structure-wise, the triazolo ring brings in nitrogen atoms in positions where they really matter for binding interactions—a fact supported by a sweep of published SAR studies. The bromo group, on the other hand, acts as a lynchpin for rapid functionalization, opening a world of analogs.
I remember the scramble to optimize a lead series targeting a tricky enzyme. Time closed in, pressure mounted, bench space ran short. The team needed diverse analogs in days, not weeks. Relying on this scaffold let us snap together a set of new compounds quickly, each one possessing modifications at the 5-position or on the amine. One batch stood out, hitting the project’s sought-after selectivity window. Peer review later confirmed what we already felt—this core created new possibilities. It turned what had looked like a dead end into a springboard for further exploration.
Colleagues in catalytic research seek robust testers for new ligands and reaction conditions. The triazolopyridine core, especially in its brominated amine form, lets reaction development chemists push catalytic boundaries without worrying about surprise decompositions or side reactions. There’s a feedback loop here—using well-behaved, reliable substrates accelerates reaction discovery, which in turn expands synthetic technique. That’s an insight gleaned from group meetings, not textbooks.
Production, purchase, and use in industrial settings always runs up against a wall of compliance and paperwork. The mainstream adoption of this compound has meant that its data sheet, purity documentation, and safety information readily meet common regulatory requirements in research labs. Unlike newer, less characterized building blocks, this one gets a smoother path from ordering to use. I’ve found that legal teams and compliance officers prefer it for just that reason—the risk profile is understood, and documentation flows predictably between institutions.
Choosing the right starting material shapes project timelines and budgets. During fragment-based screening, the amine gives a handle for bioconjugation, making it possible to generate dozens of variants with unique properties. The bromine delivers functionalization in later stages, which sidesteps labor-intensive protecting group strategies. In the last few years, I’ve benchmarked similar triazolopyridines for yield, reactivity, and handling. This one ranks high every time, especially where diverse functionalization and robust performance matter.
Research momentum often hinges on versatility and reliability. From my experience, labs working with kinase inhibitors or exploring new ligand classes routinely choose 5-Bromo-[1,2,4]triazolo[1,5-a]pyridin-2-ylamine. That choice propels projects into new territory. Publications around its use have accelerated in the literature, often pointing to not just isolated yield improvements but also richer SAR insights and faster hit-to-lead progression.
As the chemical sciences face heightened scrutiny over environmental impact, synthetic intermediates that support greener protocols carry more weight. This compound’s stability means less waste from decomposed stock solutions. Purifications after reactions, in my tests, demand less resource-intensive chromatography. That transfers directly to less solvent usage and fewer harsh reagents. While the full lifecycle assessment still depends on upstream manufacturing, those reductions count for a lot in high-throughput settings.
Mentorship means more than handing students a protocol. The best teaching tools in my lab have been those molecules that respond predictably and call for careful experiment planning. Using this triazolopyridine derivative, students grasp fundamental concepts: the reactivity of halogenated heterocycles, the strategic use of amines, and the creative possibilities in functional group transformations. Watching a student realize how a single bromine can open up a cascade of synthetic directions is among the more satisfying milestones in teaching.
Industry puts a premium on reproducibility, especially in fields like pharmaceuticals and fine chemicals where the stakes are high. The secure supply of 5-Bromo-[1,2,4]triazolo[1,5-a]pyridin-2-ylamine reduces downtime linked to batch variability. In competitive screening programs, tight batch-to-batch consistency delivers an edge by keeping data quality high and troubleshooting to a minimum. Over years of collaborative projects, I’ve watched teams move away from hit-and-miss sourcing out of necessity—predictable performance pays dividends.
On the horizon, new synthetic demands continue to crop up. Collaboration between chemists, biologists, and data scientists means building blocks are chosen not just for reactivity, but for how well they fit modeling and analytics. This molecule slots in neatly, due to its physical stability, well-understood properties, and a structure cataloged by computational platforms. From artificial intelligence-driven retrosynthesis to automated flow chemistry, the scaffold’s reliability amplifies these new methods, taking the guesswork out of the equation.
Reflecting on years of hands-on chemistry, versatility stands out as a recurring theme for drafting the next breakthrough. 5-Bromo-[1,2,4]triazolo[1,5-a]pyridin-2-ylamine continues to earn its place as a dependable, high-impact option. Its combination of physical stability, adaptable reactivity, and well-respected documentation translates to time saved and discoveries made. From the bench researcher’s perspective, it solves the right problems at the right time, supporting both incremental progress and bold leaps forward.
As projects chart new territory, recurring hurdles include sourcing speed, cost control, and unforeseen reactivity. In recent years, I’ve joined efforts to streamline supplier partnerships, which cuts both time and expenses compared to specials or in-house overhauls. Building local chemical libraries around this scaffold, labs can avoid delays in hit expansion. Combining screening with smart, AI-driven prediction tools helps preempt reactivity snags, making experimental efforts run more smoothly. Teams benefit from regular feedback, documenting why this building block gets the job done reliably, driving education, and refining best practices.
In a landscape where every day presents a new challenge, chemists lean hardest on tools that bring certainty. 5-Bromo-[1,2,4]triazolo[1,5-a]pyridin-2-ylamine has earned trust not through marketing, but through hands-on experience and a steady trail of published validation. I’ve watched it anchor drug discovery, catalysis development, and even cutting-edge materials research. Looking ahead, new fields will ask more, but this molecular backbone is set to meet the challenge—quietly, predictably, and with the kind of impact researchers value most.
